One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

Kimberly-Clark, which owns Huggies and Kleenex, is acquiring Kenvue, the maker of Tylenol, in a cash and stock deal worth ...

Kimberly-Clark said Monday it would acquire Kenvue for more than $40 billion in cash and stock, creating a consumer ...

Kimberly-Clark (NASDAQ:KMB) is making a massive bet but investors aren't sure on how to feel about it. The maker of Kleenex ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.

Shareholders of Kimberly-Clark will own about 54% of the combined company. Two years ago, Johnson & Johnson spun off its ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...